Human Islet Cell Transplantation Consortium

The Human Islet Cell Transplantation Consortium is a collaborative research group focused on developing and improving procedures to transplant insulin-producing islet cells from donor pancreases into people with type 1 diabetes. The goal is to help these individuals produce their own insulin naturally, reducing dependence on insulin injections. By studying and refining transplantation methods, the consortium aims to increase the success rate and long-term benefits of islet cell transplants, offering a potential cure or better management for those with this condition.